跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 328 条关于
“CD57”
全部
328
临床试验
168
药物
134
机构
0
资讯
26
10个月前
Abcuro's Ulviprubart Shows Promising Interim Results in Rare Blood Cancer T-LGLL
11个月前
Senescent Immune Cells Drive Immunotherapy Resistance in Cancer Through SASP-Mediated Tumor Microenvironment Remodeling
2年前
CD47-Targeted Immunotherapies Show Promise in Cancer Treatment
去年
CD47 Expression Predicts Response to Magrolimab Plus Docetaxel in Metastatic NSCLC
去年
HanchorBio's HCB101 Advances in Clinical Trials, Leading Novel CD47-Targeting Immunotherapy Pipeline
去年
Liminatus Pharma Advances Second-Generation CD47 Inhibitor IBA101 Toward 2027 Clinical Trials
去年
HanchorBio Secures $202M Licensing Deal with Henlius for Novel CD47-Targeting Cancer Immunotherapy
上个月
CD27⁻CD39⁻ CAR T Cell Count Predicts Response at Low Doses, Study Finds
去年
ALX Oncology's CD47 Inhibitor Combination with Keytruda Fails in Dual Phase II Trials
去年
Pfizer Terminates Phase II CD47 Trial in Blood Cancer Due to Recruitment Challenges
第 1 页,共 3 页
上一页
下一页